These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2624510)

  • 41. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac evaluation of mitoxantrone.
    Unverferth DV; Unverferth BJ; Balcerzak SP; Bashore TA; Neidhart JA
    Cancer Treat Rep; 1983 Apr; 67(4):343-50. PubMed ID: 6850653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Subclinical anthracycline cardiotoxicity in patients with acute promyelocytic leukemia in long-term remission after the AIDA protocol.
    Pellicori P; Calicchia A; Lococo F; Cimino G; Torromeo C
    Congest Heart Fail; 2012; 18(4):217-21. PubMed ID: 22809260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitoxantrone treatment of multiple sclerosis: safety considerations.
    Pratt RG; Boehm GA; Kortepeter CM; Racoosin JA
    Neurology; 2005 Dec; 65(12):1997; author reply 1997. PubMed ID: 16380636
    [No Abstract]   [Full Text] [Related]  

  • 45. Hemodynamic effects of chronic 4'epi-adriamycin administration.
    Milei J; Ale JJ; Garay G; Otero F; Comba AZ; Gugliotta HO; Storino RA
    Cardiovasc Drugs Ther; 1990 Dec; 4(6):1519-23. PubMed ID: 2081145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adriamycin cardiotoxicity monitoring by radionuclide scan.
    Robinson BA; Colls BM; Turner JG
    Br J Cancer; 1983 Aug; 48(2):315-7. PubMed ID: 6882671
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical evaluation of mitoxantrone in lymphoma therapy. June 6, 1990, Lugano,Switzerland. Proceedings.
    Semin Oncol; 1990 Dec; 17(6 Suppl 10):1-45. PubMed ID: 1979689
    [No Abstract]   [Full Text] [Related]  

  • 48. Assessment of ventricular function by radionuclide angiography in patients receiving 4'-epidoxorubicin and mitoxantrone.
    Vorobiof DA; Iturralde M; Falkson G
    Cancer Chemother Pharmacol; 1985; 15(3):253-7. PubMed ID: 3863718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ventricular late potentials in the assessment of mitoxantrone cardiotoxicity.
    de Leonardis V; Bartalucci S; Cinelli P; De Scalzi M; Becucci A; Lottini G; Neri B
    Cardiology; 1991; 79(2):110-5. PubMed ID: 1933962
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Echocardiographic evaluation of cardiotoxicity induced by anthracycline therapy].
    Okada Y; Horikawa K; Sano M
    Gan To Kagaku Ryoho; 1997 Mar; 24(5):585-9. PubMed ID: 9087292
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radionuclide angiographic monitoring in patients treated with potentially cardiotoxic cytostatic drugs.
    Vorobiof DA; Falkson G; Iturralde MP
    S Afr Med J; 1988 Sep; 74(5):213-6. PubMed ID: 3166211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation of ventricular function in patients treated with mitoxantrone and 4'-epidoxorubicin].
    Avilés A; Díaz-Maqueo JC; Arévila-Ceballos N; García Fernández R; López-Vancell D; Torras V
    Arch Inst Cardiol Mex; 1989; 59(6):615-8. PubMed ID: 2624510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparative study of adriamycin, epirubicin and mitoxantrone in cancer of the breast. Review of the literature].
    Delozier T; Vernhes JC
    Bull Cancer; 1991 Nov; 78(11):1013-25. PubMed ID: 1369547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mitoxantrone - an anthraquinone antibiotic with antitumor activity applied for the treatment of multiple sclerosis].
    Szwed M
    Postepy Hig Med Dosw (Online); 2014 Feb; 68():198-208. PubMed ID: 24662788
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.